{"transactions":[{"id":763432,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-26T20:12:08.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":15508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted stock units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest 100% on May 21, 2027; however, delivery of the shares is deferred until the earlier of (a) the date of the director's separation from service to Karyopharm Therapeutics Inc. and (b) a change-in-control event."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amounts reported in this Form 4 reflect the one-for fifteen reverse stock split effected by Karyopharm Therapeutics Inc. on February 25, 2025."}],"balance_after":18517,"source":{"system":"sec-edgar","filing":"0001254705-26-000008","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1254705/000125470526000008/ownership.xml","form_type":"4"}},{"id":774713,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:15:21.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":8741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 14, 2027, or the date of the Issuer's 2027 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock."}],"balance_after":71000,"source":{"system":"sec-edgar","filing":"0001254705-26-000004","document":"form4-05182026_040510.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000125470526000004/form4-05182026_040510.xml","form_type":"4"}},{"id":780639,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2026-05-13T20:05:05.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":8700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":16.49,"expiration_date":"2026-06-09","underlying":"Common Stock","underlying_shares":8700},"source":{"system":"sec-edgar","filing":"0001254705-26-000002","document":"form4-05132026_040501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000125470526000002/form4-05132026_040501.xml","form_type":"4"}},{"id":780638,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-13T20:05:05.000Z","date":"2026-05-11","kind":"sale","planned":false,"acquired":false,"shares":8700,"price":37.1829,"value":323491.23,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.18 to $37.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":62259,"source":{"system":"sec-edgar","filing":"0001254705-26-000002","document":"form4-05132026_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000125470526000002/form4-05132026_040501.xml","form_type":"4"}},{"id":780637,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-13T20:05:05.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":8700,"price":16.49,"value":143463.0,"ownership":{"direct":true},"balance_after":70959,"source":{"system":"sec-edgar","filing":"0001254705-26-000002","document":"form4-05132026_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000125470526000002/form4-05132026_040501.xml","form_type":"4"}},{"id":1130370,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2025-05-29T20:05:40.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":4600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."},{"field":"shares","element":"transactionShares","label":"F1","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests as to 100% of the underlying shares on May 28, 2026."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."}],"balance_after":4600,"derivative":{"exercise_price":4.48,"expiration_date":"2035-05-27","underlying":"Common Stock","underlying_shares":4600},"source":{"system":"sec-edgar","filing":"0000950170-25-078937","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1254705/000095017025078937/ownership.xml","form_type":"4"}},{"id":1142360,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T21:42:47.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":9791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 15, 2026, or the date of the Issuer's 2026 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock."}],"balance_after":62259,"source":{"system":"sec-edgar","filing":"0001062993-25-009808","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325009808/form4.xml","form_type":"4"}},{"id":1497625,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2024-05-30T21:19:59.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":69000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 100% of the underlying shares on May 29, 2025."}],"balance_after":69000,"derivative":{"exercise_price":0.96,"expiration_date":"2034-05-28","underlying":"Common Stock","underlying_shares":69000},"source":{"system":"sec-edgar","filing":"0000950170-24-066771","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1254705/000095017024066771/ownership.xml","form_type":"4"}},{"id":1514041,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2024-05-16T23:20:35.000Z","date":"2024-05-14","kind":"exercise","planned":false,"acquired":false,"shares":28985,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":5.73,"expiration_date":"2025-03-19","underlying":"Common Stock","underlying_shares":28985},"source":{"system":"sec-edgar","filing":"0001062993-24-010536","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299324010536/form4.xml","form_type":"4"}},{"id":1514040,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-16T23:20:35.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":7693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on May 16, 2025, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock."}],"balance_after":52468,"source":{"system":"sec-edgar","filing":"0001062993-24-010536","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299324010536/form4.xml","form_type":"4"}},{"id":1514039,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-16T23:20:35.000Z","date":"2024-05-14","kind":"sale","planned":false,"acquired":false,"shares":28985,"price":32.3033,"value":936311.1505,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.00 to $32.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":44775,"source":{"system":"sec-edgar","filing":"0001062993-24-010536","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299324010536/form4.xml","form_type":"4"}},{"id":1514038,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-16T23:20:35.000Z","date":"2024-05-14","kind":"exercise","planned":false,"acquired":true,"shares":28985,"price":5.73,"value":166084.05,"ownership":{"direct":true},"balance_after":73760,"source":{"system":"sec-edgar","filing":"0001062993-24-010536","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299324010536/form4.xml","form_type":"4"}},{"id":1782771,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-12T20:07:40.000Z","date":"2023-09-12","kind":"purchase","planned":false,"acquired":true,"shares":41140,"price":1.215,"value":49985.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.1935 to $1.24, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.."}],"balance_after":45140,"source":{"system":"sec-edgar","filing":"0000950170-23-047712","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1254705/000095017023047712/ownership.xml","form_type":"4"}},{"id":1877792,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2023-05-25T20:05:02.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 100% of the underlying shares on May 24, 2024."}],"balance_after":34000,"derivative":{"exercise_price":2.5,"expiration_date":"2033-05-23","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001209191-23-032138","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1254705/000120919123032138/doc4.xml","form_type":"4"}},{"id":1884326,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T20:37:52.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":9792,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 18, 2024, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock."}],"balance_after":44775,"source":{"system":"sec-edgar","filing":"0001062993-23-011813","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299323011813/form4.xml","form_type":"4"}},{"id":2259744,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-23T20:43:25.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":14035,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 19, 2023, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock."}],"balance_after":34983,"source":{"system":"sec-edgar","filing":"0001062993-22-013300","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299322013300/form4.xml","form_type":"4"}},{"id":2261553,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2022-05-20T20:03:41.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":23900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 100% of the underlying shares on the earlier of May 19, 2023 or the next annual meeting of stockholders of Karyopharm Therapeutics Inc."}],"balance_after":23900,"derivative":{"exercise_price":5.65,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":23900},"source":{"system":"sec-edgar","filing":"0001209191-22-030956","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1254705/000120919122030956/doc4.xml","form_type":"4"}},{"id":2698581,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-24T21:14:28.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":9941,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 20, 2022, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock."}],"balance_after":20948,"source":{"system":"sec-edgar","filing":"0001192482-21-000453","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000453/edgar.xml","form_type":"4"}},{"id":2700540,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2021-05-21T21:31:49.000Z","date":"2021-05-21","kind":"grant","acquired":true,"shares":23900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 100% of the underlying shares on the earlier of May 21, 2022 or the next annual meeting of stockholders of Karyopharm Therapeutics Inc. (the \"Issuer\"), provided that the reporting person continues to serve as a director of the Issuer through such date."}],"balance_after":23900,"derivative":{"exercise_price":9.42,"expiration_date":"2031-05-20","underlying":"Common Stock","underlying_shares":23900},"source":{"system":"sec-edgar","filing":"0001209191-21-035024","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1254705/000120919121035024/doc4.xml","form_type":"4"}},{"id":2720639,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-10T23:57:22.000Z","date":"2021-05-06","kind":"purchase","acquired":true,"shares":4000,"price":7.82,"value":31280.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-21-031437","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1254705/000120919121031437/doc4.xml","form_type":"4"}},{"id":3134875,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2020-05-26T20:18:43.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":16400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 100% of the underlying shares on May 21, 2021, provided that the reporting person continues to serve as a director of the issuer through such date."}],"balance_after":16400,"derivative":{"exercise_price":19.11,"expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":16400},"source":{"system":"sec-edgar","filing":"0001209191-20-032001","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1254705/000120919120032001/doc4.xml","form_type":"4"}},{"id":3136885,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-05-22T20:20:55.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":8095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable on May 20, 2021, subject to the director's continued service with the issuer."}],"balance_after":8095,"derivative":{"exercise_price":22.05,"expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":8095},"source":{"system":"sec-edgar","filing":"0001192482-20-000361","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248220000361/edgar.xml","form_type":"4"}},{"id":3136884,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-22T20:20:55.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":4047,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 20, 2021, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock."}],"balance_after":11007,"source":{"system":"sec-edgar","filing":"0001192482-20-000361","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248220000361/edgar.xml","form_type":"4"}},{"id":3493859,"issuer":{"id":147285,"kind":"organization","name":"TETRAPHASE PHARMACEUTICALS INC","symbol":"TTPH"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-06-11T23:17:10.000Z","date":"2019-06-10","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in equal quarterly installments over a one-year period measured from the date of grant."}],"balance_after":16500,"derivative":{"exercise_price":0.77,"expiration_date":"2029-06-09","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-19-036254","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1254705/000120919119036254/doc4.xml","form_type":"4"}},{"id":3496839,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2019-06-07T12:53:54.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 100% of the underlying shares on June 6, 2020, provided that the reporting person continues to serve as a director of the issuer through such date."}],"balance_after":25000,"derivative":{"exercise_price":5.43,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-035373","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1254705/000120919119035373/doc4.xml","form_type":"4"}},{"id":3546551,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2019-04-29T22:42:11.000Z","date":"2019-04-25","kind":"grant","acquired":true,"shares":9414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable on April 25, 2020, subject to the director's continued service with the issuer."}],"balance_after":9414,"derivative":{"exercise_price":14.57,"expiration_date":"2029-04-25","underlying":"Common Stock","underlying_shares":9414},"source":{"system":"sec-edgar","filing":"0001192482-19-000211","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248219000211/edgar.xml","form_type":"4"}},{"id":3546550,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-29T22:42:11.000Z","date":"2019-04-25","kind":"grant","acquired":true,"shares":4707,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on April 25, 2020, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock."}],"balance_after":6960,"source":{"system":"sec-edgar","filing":"0001192482-19-000211","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248219000211/edgar.xml","form_type":"4"}},{"id":3886977,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2018-06-20T20:25:14.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 100% of the underlying shares on June 19, 2019, provided that the reporting person continues to serve as a director of the issuer through such date."}],"balance_after":17000,"derivative":{"exercise_price":18.8,"expiration_date":"2028-06-18","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-18-038771","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1254705/000120919118038771/doc4.xml","form_type":"4"}},{"id":3898130,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-11T20:31:24.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":12700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on June 8, 2018 and the shares underlying this option will vest 100% at the earlier of (i) June 8, 2019 and (ii) the Issuer's next annual meeting of stockholders."}],"balance_after":12700,"derivative":{"exercise_price":2.5,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":12700},"source":{"system":"sec-edgar","filing":"0001171843-18-004578","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1254705/000117184318004578/formfour.xml","form_type":"4"}},{"id":3910423,"issuer":{"id":147285,"kind":"organization","name":"TETRAPHASE PHARMACEUTICALS INC","symbol":"TTPH"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-06-01T20:12:53.000Z","date":"2018-05-30","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in equal quarterly installments over a one-year period measured from the date of grant."}],"balance_after":12500,"derivative":{"exercise_price":3.68,"expiration_date":"2028-05-29","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-18-034652","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1254705/000120919118034652/doc4.xml","form_type":"4"}},{"id":3915227,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2018-05-29T21:05:38.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":4506,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable on May 24, 2019, subject to the director's continued service with the issuer."}],"balance_after":4506,"derivative":{"exercise_price":24.95,"expiration_date":"2028-05-24","underlying":"Common Stock","underlying_shares":4506},"source":{"system":"sec-edgar","filing":"0001192482-18-000253","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248218000253/edgar.xml","form_type":"4"}},{"id":3915226,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-29T21:05:38.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":2253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 24, 2019, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date in shares of the issuer's common stock."}],"balance_after":2253,"source":{"system":"sec-edgar","filing":"0001192482-18-000253","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248218000253/edgar.xml","form_type":"4"}},{"id":4163431,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-14T22:02:15.000Z","date":"2017-11-14","kind":"grant","acquired":true,"shares":3812,"price":1.889,"value":7200.868,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The purchase price of $1.889 is reflective of the weighted average purchase price of all transactions reported on this line. The prices for the transactions reported on this line range from $1.71 to $1.911. The reporting person undertakes to provide Proteon Therapeutics, Inc., any security holder of Proteon Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":53312,"source":{"system":"sec-edgar","filing":"0001171843-17-007020","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1254705/000117184317007020/formfour.xml","form_type":"4"}},{"id":4163430,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-14T22:02:15.000Z","date":"2017-11-13","kind":"grant","acquired":true,"shares":25700,"price":1.918,"value":49292.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The purchase price of $1.918 is reflective of the weighted average purchase price of all transactions reported on this line. The prices for the transactions reported on this line range from $1.905 to $1.96. The reporting person undertakes to provide Proteon Therapeutics, Inc., any security holder of Proteon Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":49500,"source":{"system":"sec-edgar","filing":"0001171843-17-007020","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1254705/000117184317007020/formfour.xml","form_type":"4"}},{"id":4163429,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-14T22:02:15.000Z","date":"2017-11-10","kind":"grant","acquired":true,"shares":23800,"price":1.963,"value":46719.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchase price of $1.963 is reflective of the weighted average purchase price of all transactions reported on this line. The prices for the transactions reported on this line range from $1.91 to $2.01. The reporting person undertakes to provide Proteon Therapeutics, Inc., any security holder of Proteon Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":23800,"source":{"system":"sec-edgar","filing":"0001171843-17-007020","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1254705/000117184317007020/formfour.xml","form_type":"4"}},{"id":4275144,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-21T20:17:32.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":6666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on June 20, 2017 and the shares underlying this option will vest 100% at the earlier of (i) June 20, 2018 and (ii) the Issuer's next annual meeting of stockholders."}],"balance_after":6666,"derivative":{"exercise_price":1.3,"expiration_date":"2027-06-19","underlying":"Common Stock, $0.001 par value","underlying_shares":6666},"source":{"system":"sec-edgar","filing":"0001171843-17-003745","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1254705/000117184317003745/formfour.xml","form_type":"4"}},{"id":4278722,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2017-06-16T20:38:41.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 100% of the underlying shares on June 15, 2018, provided that the holder continues to serve as a director of the issuer through such date."}],"balance_after":17000,"derivative":{"exercise_price":9.18,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-17-040536","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1254705/000120919117040536/doc4.xml","form_type":"4"}},{"id":4297825,"issuer":{"id":147285,"kind":"organization","name":"TETRAPHASE PHARMACEUTICALS INC","symbol":"TTPH"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2017-06-01T21:00:24.000Z","date":"2017-05-31","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in equal quarterly installments over a one-year period measured from the date of grant."}],"balance_after":12500,"derivative":{"exercise_price":6.89,"expiration_date":"2027-05-30","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-17-036836","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1254705/000120919117036836/doc4.xml","form_type":"4"}},{"id":4304500,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2017-05-25T20:42:43.000Z","date":"2017-05-24","kind":"grant","acquired":true,"shares":19853,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on May 24, 2018, subject to the director's continued service with the issuer."}],"balance_after":19853,"derivative":{"exercise_price":9.33,"expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":19853},"source":{"system":"sec-edgar","filing":"0001192482-17-000140","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248217000140/edgar.xml","form_type":"4"}}]}